Author

Tilia Zinnecker

Observed name: Zinnecker, Tilia Marlene

Institution: Max Planck Institute for Dynamics of Complex Technical Systems

Observed institution: Max Planck Institute for Dynamics of Complex Technical Systems

ORCID: 0009-0008-9514-3069

Observed ORCID: 0009-0008-9514-3069

OpenAlex ID: A5093954165

Innovations in cell culture-based influenza vaccine manufacturing – from static cultures to high cell density cultivations

2024 · Tilia Zinnecker, Udo Reichl, et al. · Human Vaccines & Immunotherapeutics · 24

From single‐cell cloning to high‐yield influenza virus production – implementing advanced technologies in vaccine process development

2024 · Tilia Zinnecker, Najd Badri, et al. · Engineering in Life Sciences · 13

Seed Train Intensification and TFDF-Based Perfusion for MDCK Cell-Based Influenza A Virus Production

2025 · Tilia Zinnecker, Emelie Wicke, et al. · Processes · 4

Influenza A Virus Production Following Quality by Design Principles

2025 · Tilia Zinnecker, Kristin Thiele, et al. · Engineering in Life Sciences · 2

Lipidomic profiling of influenza A virus production in MDCK cells towards targeted clone selection

2026 · Jocelyn A. Menard, Tilia Zinnecker, et al. · Scientific Reports · 1

Optimization of YF17D-Vectored Zika Vaccine Production by Employing Small-Molecule Viral Sensitizers to Enhance Yields

2025 · Sven Göbel, Tilia Zinnecker, et al. · Vaccines · 1

Advancing cell-based influenza vaccine production : from clonal MDCK selection to robust and intensified upstream processes

2026 · Zinnecker, Tilia Marlene · MPG.PuRe (Max Planck Society)

Quantitative analysis of proteomic changes in two monoclonal suspension MDCK cell lines infected with human influenza A virus (H1N1)

2025 · Jan Küchler, Tilia Zinnecker, et al. · PLoS ONE

Works count: 8

Citation count: 45

H-index: 3

I10-index: 2